EIC Cell and Gene Therapy Strategic Plan Published
The EIC’s Cell and Gene Therapy Portfolio Strategic Plan includes activities that benefit all six projects within the Portfolio.
Where Can You Find Us in 2024?
Our consortium anticipates being as prolific in 2024 as they plan to continue representing PAT4CGT and their respective organisations at a series of high-level events across Europe and North America.
Dr Luc Henry Speaks at ESGCT Congress and EIC symposium
Between October 24-27, members of the PAT4CGT consortium actively participated in the European Society of Gene and Cell Therapy's 30th Annual Congress.
PAT4CGT Functional Prototype Developed
The PAT4CGT project reached its first milestone in September when our partners at Jobst Technologies constructed our first at-line monitoring prototype.
CGT Helix Featured in FirstWord Pharma
Welcome to the first edition of the PAT4CGT Newsletter
Our first newsletter includes details on the conferences and events that our consortium partners will be attending, hand-picked articles from the world of CGT research and Updates on the progress we have been making.
International CGT Experts Invited to Join EU-Funded Global Collaboration Hub
Innovaud Features Work of PAT4CGT Project Consortium Partners - Limula
In the wide-ranging interview with Innovaud News, Dr Thomas Eaton spoke at length about the Limula, the bottlenecks limiting current CGT manufacturing and the supportive business environment in Switzerland.
Iordanis Arzimanoglou References CGT Pathfinder Challenge in Science Business Interview
Iordanis Arzimanoglou, EIC Program Manager for health and biotechnology, spoke to Science|Business about the European Innovation Council’s pathfinder programme aimed at Europe’s cell and gene therapy sector.
PAT4CGT Press Release
PAT4CGT Consortium Announces Prestigious €4.7M Pathfinder Grant Awarded by European Innovation Council.